rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Progyny, Inc.

PGNY · Nasdaq

Health CareProviders & FacilitiesLeading

PGNY stood above a rising 150-day average in 33 of the last 52 weekly readings, including each of the last 22 weeks. It is 14.2% above that average now. Providers & Facilities: 47% of its 53 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
22 in a row
Industry in uptrend
47% -2 in 4 wk
Insider buys, 12 months
$1.9M
Insider sales, 12 months
$4.6M
Officials’ trades on record
9
Institutions holding
283 (+24)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 33 of 52 weeks.

21 Apr – 20 Oct
27%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.2M$0$5.0MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

9 disclosed lines: House 5, Senate 0, executive 4; 3 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k30 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k4 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k26 Feb 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k26 Jan 2026filed 14 May 2026
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k6 Dec 2024filed 14 Jan 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k30 Jul 2020filed 19 Aug 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k30 Jun 2020filed 17 Jul 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k1 Jun 2020filed 16 Jun 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k21 May 2020filed 16 Jun 2020

Insiders

Buy orders, 12 months1
Sale orders, 12 months23
Buyers · sellers1 · 6
WhoDidSharesTraded
Melissa B. CummingsChief Operating Officersold1,879at $28.0014 Oct 2026filed 16 Oct 2026
Allison SwartzEVP, GCsold3,903at $26.1023 Sep 2026filed 28 Sep 2026
Kevin K. GordonDirectorsold11,500at $27.9410 Sep 2026filed 14 Sep 2026
Kevin K. GordonDirectorsold11,500at $27.1210 Sep 2026filed 18 Sep 2026
Melissa B. CummingsChief Operating Officersold2,244at $31.6014 Jul 2026filed 16 Jul 2026
Allison SwartzEVP, GCsold599at $25.084 Jun 2026filed 5 Jun 2026
Mark S. LivingstonCHIEF FINANCIAL OFFICERsold1,918at $25.504 Jun 2026filed 5 Jun 2026
Mark S. LivingstonCHIEF FINANCIAL OFFICERsold599at $25.504 Jun 2026filed 5 Jun 2026
Allison SwartzEVP, GCsold1,199at $25.023 Jun 2026filed 5 Jun 2026
Geoffrey ClappChief Product Officersold1,530at $25.582 Jun 2026filed 3 Jun 2026
Mark S. LivingstonCHIEF FINANCIAL OFFICERsold279at $26.202 Jun 2026filed 3 Jun 2026
Cheryl ScottDirectorsold7,439at $26.391 Jun 2026filed 3 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders283+24 on the quarter
New · exited71 · 46
Reported value$2.2B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.reduced · filed 7 Aug 202611,599,921$334.4M-398,546−3.3%
FMR LLCadded · filed 13 Aug 20267,004,280$201.9M+503,461+7.7%
VANGUARD PORTFOLIO MANAGEMENT LLCnew · filed 13 Aug 20265,019,465$144.7M+5,019,465
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 20263,210,723$92.6M+3,210,723
STATE STREET CORPreduced · filed 7 Aug 20263,022,859$87.1M-57,434−1.9%
AMERIPRISE FINANCIAL INCreduced · filed 14 Aug 20262,763,514$79.7M-61,817−2.2%
FORT WASHINGTON INVESTMENT ADVISORS INCreduced · filed 17 Jul 20262,548,164$73.5M-145,229−5.4%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 20261,969,208$56.8M-73,757−3.6%
CITADEL ADVISORS LLCnew · filed 14 Aug 20261,785,717$51.5M+1,785,717
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,688,670$48.7M+115,245+7.3%
31 Mar 2023 – 30 Jun 2026
223254285Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Melissa B. Cummings Company insiderChief Operating Officer · last 14 Oct 20260 · 3
Allison Swartz Company insiderEVP, GC · last 23 Sep 20260 · 11
Geoffrey Clapp Company insiderChief Product Officer · last 17 Sep 20260 · 1
Kevin K. Gordon Company insiderDirector · last 10 Sep 20260 · 6
Mark S. Livingston Company insiderCHIEF FINANCIAL OFFICER · last 4 Sep 20260 · 16
Peter Anevski Company insiderCHIEF EXECUTIVE OFFICER · last 3 Sep 20262 · 121
Cheryl Scott Company insiderDirector · last 1 Jun 20260 · 6
Debra L. Morris Company insiderDirector · last 21 May 20260 · 0
Elizabeth D. Bierbower Company insiderDirector · last 21 May 20260 · 0
Jeffrey G. Park Company insiderDirector · last 21 May 20260 · 0
Lloyd H. Dean Company insiderDirector · last 21 May 20260 · 0
Norman Payson Company insiderDirector · last 21 May 20260 · 213

Same industry

PACS PACS GroupLeading+19%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202595.6%
Operating profit marginFY 2025 · to 31 Dec 202526.8%
Free cash flow marginFY 2025 · to 31 Dec 202560.2%
Return on capital employedFY 2025 · to 31 Dec 202515.8%
Research spendFY 2025 · to 31 Dec 20253.0%
Revenue growthFY 2025 · to 31 Dec 20251.6%
Earnings per share growthFY 2025 · to 31 Dec 2025333%
Share count trendFY 2025 · to 31 Jan 2026-1.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$112.2M
Free cash flowFY 2025 · to 31 Dec 2025$191.8M

Analyst forecasts

No analyst forecasts yet.